Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights

Magnetic Resonance in Medicine

Volumn 39, Issue 2, 1998, Pages 259-269

  Su, Min Ying ^a   Mühler, Andreas ^b   Lao, Xiaoyan ^a   Nalcioglu, Orhan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYER PHARMA AG   (Germany)

Author keywords

MR contrast agents; Tumor growth; Vascular leakage; Vascular volume

Indexed keywords

GADOLINIUM COMPOUNDS; MAGNETIC RESONANCE IMAGING; MOLECULAR WEIGHT;

DYNAMIC CONTRAST ENHANCED; DYNAMIC CONTRAST ENHANCED MRI; MR CONTRAST AGENTS; PHARMACOKINETIC MODEL; TUMOR CHARACTERIZATION; TUMOR GROWTH; VASCULAR PERMEABILITY; VASCULAR VOLUME;

TUMORS;

CONTRAST MEDIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER; CARCINOSARCOMA; CONTRAST ENHANCEMENT; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR GROWTH;

EID: 0031886171     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910390213     Document Type: Article

References (40)

1. R. K. Jain, Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6, 559-593 (1987).
2. H. F. Dvorak, Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy, in "Effects of Therapy on Biology and Kinetics of the Residual Tumor, Part A: Pre-Clinical Aspects," p. 317-330, Wiley-Liss Inc., 1990.
3. H. F. Dvorak, Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659 (1986).
4. J. A. Nagy, L. F. Brown, D. R. Senger, N. Lanir, L. Van de Water, A. M. Dvorak, H. F. Dvorak, Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta 948, 305-326 (1988).
5. D. R. Senger, L. Van de Water, L. F. Brown, J. A. Nagy, K. T. Yeo, B. Berse, R. W. Jackman, A. M. Dvorak, H. F. Dvorak, Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12, 303-324 (1993).
6. A. J. Potgens, H. R. Westphal, R. M. de Waal, D. J. Ruiter, The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. Biol. Chem. Hoppe-Seyler 376, 57-70 (1995).
7. P. Tofts, A. Kermode, Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn. Reson. Med. 17, 357-367 (1991).
8. M.-Y. Su, J.-C. Jao, O. Nalcioglu, Measurements of vascular volume fraction and blood-tissue permeability constants with pharmacokinetic model: studies in rat muscle tumor. Magn. Reson. Med. 32, 714-724 (1994).
9. R. Hilf, I. Michel, C. Bell, J. J. Freeman, A. Borman, Biochemical and morphologic properties of a new lactating mammary tumor line in the rats. Cancer Res. 25, 286-299 (1965).
10. H. Degani, E. Furman, S. Fields, Magnetic resonance imaging and spectroscopy of MCF7 human breast cancer: pathophysiology and monitoring of treatment. Clin. Chim. Acta 228, 19-33 (1994).
11. E. Goldstein, K. Burnett, J. Hansell, J. Casaia, J. Dizon, B. Farrar, D. Gelblum, G. Wolf, Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties, and pharmacokinetics. Physiol. Chem. Phys. 16, 97-104 (1984).
12. G. Schuhmann-Giampieri, H. Schmitt-Willich, T. Frenzel, W.-R. Press, H.-J. Weinmann, In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest. Radiol. 26, 969-974 (1991).
13. E. C. Wiener, M. Brechbiel, W. H. Brothers, R. L. Magin, O. A. Gansow, D. A. Tomalia, P. C. Lauterbur, Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents, Magn. Reson. Med. 31, 1-8 (1994).
14. H. C. Schwickert, T. P. Roberts, A. Muhler, M. Stiskal, F. Demsar, R. C. Brasch, Angiographic properties of Gd-DTPA-24-cascade-polymer - a new macromolecular MR contrast agent. Eur. Radiol. 20, 144-150 (1995).
15. V. S. Vexler, O. Clement, H. Schmitt-Willich, R. C. Brasch, Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns. J. Magn. Reson. Imaging 4, 381-388 (1994).
16. D. Shames, R. Kuwatsuru, V. Vexler, A. Muhler, R. C. Brasch, Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn. Reson. Med. 29, 616-622 (1993).
17. R. Kuwatsuru, D. Shames, A. Muhler, J. Mintorovitch, V. Vexler, J. Mann, F. Cohn, D. Price, J. Huberty, R. C. Brasch, Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn. Reson. Med. 30, 76-81 (1993).
18. S. Koenig, M. Spiller, R. Brown, G. Wolf, Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA). Magn. Reson. Med. 3, 791-795 (1986).
19. G. Strich, P. Hagan, K. Gerber, R. Slutsky, Tissue distribution and magnetic resonance spin lattice relaxation effects of Gadolinium-DTPA. Radiology 154, 723-726 (1985).
20. M.-Y. Su, A. A. Najafi, O, Nalcioglu, Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn. Reson. Med. 34, 402-411 (1995).
21. M.-Y. Su, X. Lao, O. Nalcioglu, Quantitative comparison of pharmacokinetics of polylysine-Gd-DTPA. Gd-DTPA-24-cascade-polymer, and Gd-DTPA in blood, liver, and tumor of rats, in "Proc., SMR, 4th Annual Meeting, New York, 1996," p.1697.
22. H.-J. Weinmann, R. C. Brasch, W.-R. Press, G. E. Wesbey, Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142, 619-624 (1984).
23. H.-J. Weinmann, M. Laniado, W. Mutzel, Pharmacokinetics of gadolinium DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol. Chem. Phys. Med. NMR 16, 167-172 (1984).
24. 99mTc(DTPA) in rats. Magn. Reson. Imaging 8, 567-575 (1990).
25. R. K. Jain, Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl. Cancer Inst. 81, 570-576 (1989).
26. L. T. Baxter, R. K. Jain, Transport of molecules in the tumor interstitium: a review. Cancer Res. 47, 3039-3051 (1987).
27. 1 contrast agents: accuracy, precision, and water exchange. Magn. Reson. Med. 36, 858-867 (1996).
28. 1 inversion recovery echoplanar imaging (ULSTIR-EPT), with dynamic 3D gradient-recalled echo imaging. Magn. Reson. Med. 34, 845-852 (1995).
29. K. M. Donahue, R. M. Weisskoff, D. J. Parmelee, R. J. Callahan, R. A. Wilkinson, J. B. Mandeville, B. R. Rosen, Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction. Magn. Reson. Med. 34, 423-432 (1995).
30. R. K. Jain, L. T. Baxter, Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 48, 7022-7032 (1988).
31. J. R. Less, M. C. Posner, Y. Boucher, D. Borochovitz, N. Wolmark, R. K. Jain, Interstitial hypertension in human breast and colorectal tumors. Cancer Res. 52, 6371-6374 (1992).
32. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D. A. Berk, V. P. Torchilin, R. K. Jain, Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55, 3752-3756 (1995).
33. C. F. van Dijke, R. C. Brasch, T. P. Roberts, N. Weidner, A. Mathur, D. M. Shames, J. S. Mann, F. Demsar, P. Lang, H. C. Schwickert, Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histological capillary density. Radiology 198, 813-818 (1996).
34. G. R. Criscuolo, The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. Yale J. Biol. Med. 66, 277-314 (1993).
35. J. Strugar, D. Rothbart, W. Harrington, G. R. Criscuolo, Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J. Neurosurg. 81, 560-566 (1994).
36. K. Weindel, J. R. Moringlane, D. Marme, H. A. Weich, Detection and quantification of vascular endothelial growth factor/vascular perme-ability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 35, 439-448 (1994).
37. M. Asano, A. Yukita, T. Matsumoto, S. Kondo, H. Suzuki, Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor-121. Cancer Res. 55, 5296-5301 (1995).
38. L. F. Brown, B. Berse, R. W. Jackman, K. Tognazzi, A. J. Guidi, H. F. Dvorak, D. R. Senger, J. L. Connolly, S. J. Schnitt, Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26, 86-91 (1995).
39. G. M. Abu-Jawdeh, J. D. Faix, J. Niloff, K. Tognazzi, E. Manseau, H. F. Dvorak, L. F. Brown, Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab. Invest. 74, 1105-1115 (1996).
40. R. C. Brasch, C. Pham, D. Shames, T. Roberts, K. van Dijke, N. van Bruggen, J. Mann, S. Ostrowitzki, O. Melnyk, Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J. Magn. Reson. Imaging 7, 68-74 (1997).